Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator.

Shuichi Suzuki, Stella Kidwell, Sidney Starkman, Jeffrey L. Saver, Gary Duckwiler, Fernando Vinuela, Bruce Ovbiagele

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Options are limited for individuals who present to the ED within 3 hours of ischemic stroke onset, but who are deemed ineligible for intravenous thrombolysis. Multimodal MRI has been shown to be of great help in identifying stroke patients with large areas of at risk "penumbral tissue", who may gain from the use of novel endovascular therapies. We report a patient who twice benefited from this management approach, in the setting of hemorrhagic risk following successive ischemic strokes. CASE DESCRIPTION: The patient is a 78 year old male who experienced acute ischemic stroke on 2 separate occasions 5 months apart, and for whom perceived contraindications to appropriate thrombolytic therapy administration led to the successful use of different endovascular therapies at each encounter. Furthermore, following mechanical clot retrieval during the second encounter, the high intensity signal area noted on the baseline diffusion weighted imaging (DWI) in the posterior circulation territory, was almost completely resolved on the day 7 post-procedure MRI. CONCLUSIONS: To our knowledge, this is the first reported case of reversal of a DWI abnormality in the posterior circulation territory.

Original languageEnglish (US)
JournalStroke
Volume36
Issue number9
StatePublished - 2005
Externally publishedYes

Fingerprint

Tissue Plasminogen Activator
Stroke
Thrombolytic Therapy
Therapeutics

Cite this

Suzuki, S., Kidwell, S., Starkman, S., Saver, J. L., Duckwiler, G., Vinuela, F., & Ovbiagele, B. (2005). Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator. Stroke, 36(9).

Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator. / Suzuki, Shuichi; Kidwell, Stella; Starkman, Sidney; Saver, Jeffrey L.; Duckwiler, Gary; Vinuela, Fernando; Ovbiagele, Bruce.

In: Stroke, Vol. 36, No. 9, 2005.

Research output: Contribution to journalArticle

Suzuki, S, Kidwell, S, Starkman, S, Saver, JL, Duckwiler, G, Vinuela, F & Ovbiagele, B 2005, 'Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator.', Stroke, vol. 36, no. 9.
Suzuki, Shuichi ; Kidwell, Stella ; Starkman, Sidney ; Saver, Jeffrey L. ; Duckwiler, Gary ; Vinuela, Fernando ; Ovbiagele, Bruce. / Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator. In: Stroke. 2005 ; Vol. 36, No. 9.
@article{51d2ef4628174cf08d60277c9266c18b,
title = "Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator.",
abstract = "BACKGROUND AND PURPOSE: Options are limited for individuals who present to the ED within 3 hours of ischemic stroke onset, but who are deemed ineligible for intravenous thrombolysis. Multimodal MRI has been shown to be of great help in identifying stroke patients with large areas of at risk {"}penumbral tissue{"}, who may gain from the use of novel endovascular therapies. We report a patient who twice benefited from this management approach, in the setting of hemorrhagic risk following successive ischemic strokes. CASE DESCRIPTION: The patient is a 78 year old male who experienced acute ischemic stroke on 2 separate occasions 5 months apart, and for whom perceived contraindications to appropriate thrombolytic therapy administration led to the successful use of different endovascular therapies at each encounter. Furthermore, following mechanical clot retrieval during the second encounter, the high intensity signal area noted on the baseline diffusion weighted imaging (DWI) in the posterior circulation territory, was almost completely resolved on the day 7 post-procedure MRI. CONCLUSIONS: To our knowledge, this is the first reported case of reversal of a DWI abnormality in the posterior circulation territory.",
author = "Shuichi Suzuki and Stella Kidwell and Sidney Starkman and Saver, {Jeffrey L.} and Gary Duckwiler and Fernando Vinuela and Bruce Ovbiagele",
year = "2005",
language = "English (US)",
volume = "36",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator.

AU - Suzuki, Shuichi

AU - Kidwell, Stella

AU - Starkman, Sidney

AU - Saver, Jeffrey L.

AU - Duckwiler, Gary

AU - Vinuela, Fernando

AU - Ovbiagele, Bruce

PY - 2005

Y1 - 2005

N2 - BACKGROUND AND PURPOSE: Options are limited for individuals who present to the ED within 3 hours of ischemic stroke onset, but who are deemed ineligible for intravenous thrombolysis. Multimodal MRI has been shown to be of great help in identifying stroke patients with large areas of at risk "penumbral tissue", who may gain from the use of novel endovascular therapies. We report a patient who twice benefited from this management approach, in the setting of hemorrhagic risk following successive ischemic strokes. CASE DESCRIPTION: The patient is a 78 year old male who experienced acute ischemic stroke on 2 separate occasions 5 months apart, and for whom perceived contraindications to appropriate thrombolytic therapy administration led to the successful use of different endovascular therapies at each encounter. Furthermore, following mechanical clot retrieval during the second encounter, the high intensity signal area noted on the baseline diffusion weighted imaging (DWI) in the posterior circulation territory, was almost completely resolved on the day 7 post-procedure MRI. CONCLUSIONS: To our knowledge, this is the first reported case of reversal of a DWI abnormality in the posterior circulation territory.

AB - BACKGROUND AND PURPOSE: Options are limited for individuals who present to the ED within 3 hours of ischemic stroke onset, but who are deemed ineligible for intravenous thrombolysis. Multimodal MRI has been shown to be of great help in identifying stroke patients with large areas of at risk "penumbral tissue", who may gain from the use of novel endovascular therapies. We report a patient who twice benefited from this management approach, in the setting of hemorrhagic risk following successive ischemic strokes. CASE DESCRIPTION: The patient is a 78 year old male who experienced acute ischemic stroke on 2 separate occasions 5 months apart, and for whom perceived contraindications to appropriate thrombolytic therapy administration led to the successful use of different endovascular therapies at each encounter. Furthermore, following mechanical clot retrieval during the second encounter, the high intensity signal area noted on the baseline diffusion weighted imaging (DWI) in the posterior circulation territory, was almost completely resolved on the day 7 post-procedure MRI. CONCLUSIONS: To our knowledge, this is the first reported case of reversal of a DWI abnormality in the posterior circulation territory.

UR - http://www.scopus.com/inward/record.url?scp=33644797466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644797466&partnerID=8YFLogxK

M3 - Article

C2 - 16051897

AN - SCOPUS:33644797466

VL - 36

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 9

ER -